JANX
Janux Therapeutics (JANX)
$28
About Janux Therapeutics (JANX)
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
Details
Daily high
$24.46
Daily low
$23.44
Price at open
$23.44
52 Week High
$71.71
52 Week Low
$22.48
Market cap
1.4B
Dividend yield
0.00%
Volume
931,458
Avg. volume
1.1M
P/E ratio
-17.12
Janux Therapeutics News
Details
Daily high
$24.46
Daily low
$23.44
Price at open
$23.44
52 Week High
$71.71
52 Week Low
$22.48
Market cap
1.4B
Dividend yield
0.00%
Volume
931,458
Avg. volume
1.1M
P/E ratio
-17.12